← Leaderboards
Marc Larochelle
University Of Michigan At Ann Arbor
$5,973,869
Attributed
$7,654,206
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,256,857 · 4
CDC$799,823 · 1
AHRQ$597,526 · 1
By mechanism
R01$4,167,710 · 2
R33$1,133,577 · 1
K23$955,570 · 1
U01$799,823 · 1
T32$597,526 · 1
Top collaborators
- Emily Elizabeth Hurstak3 shared
- Amy S B Bohnert2 shared
- Lewei Allison Lin2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- John Malcolm Hollingsworth$8,254,178
- Renny T Franceschi$12,495,585
- Thomas G Robins$10,229,414
- Vahakn B Shahinian$9,253,721
- Richard A Hirth$9,054,960
Others in their field
Other Emerging Leaders on “Health Services Research”
- Leonard Freedman · Leidos Biomedical Research, Inc.$854,007,879
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lynn Briscoe · Leidos Biomedical Research, Inc.$237,953,605
- Joel A Lipkin · Four Points Technology, Llc$183,862,844
- Leonard Freedmand · Leidos Biomedical Research, Inc.$179,493,316
- Kimberly Smith · Ppd Development Lp$122,921,392
Research focus
Health Services ResearchObservational StudyEffectivenessDatabasesAddictionOpioidData SourcesMortalityMorbidity - Disease RateLinkMedicalBaseOutpatientsTrial ComparingClinical PracticeComparative EffectivenessPoliciesCompare EffectivenessHigh RiskHospitalsOpioid UseBuprenorphineMonitorOpioid Mortality
Grant awards (19)
Evaluating real-world effectiveness of tele-buprenorphine: A mixed-methods study to develop clinical guidance$675,731
R01 · FY2025 · DA
MOUD Comparative Effectiveness Study$542,395
R01 · FY2025 · DA · contact PI
Evaluating real-world effectiveness of tele-buprenorphine: A mixed-methods study to develop clinical guidance$751,543
R01 · FY2024 · DA
MOUD Comparative Effectiveness Study$542,395
R01 · FY2024 · DA · contact PI
Training in Health Services Research for Vulnerable Populations$257,896
T32 · FY2024 · HS · contact PI
MOUD Comparative Effectiveness Study$522,575
R01 · FY2023 · DA · contact PI
Training in Health Services Research for Vulnerable Populations$339,630
T32 · FY2023 · HS · contact PI
Records for Alcohol Care Enhancement (RACE)$333,043
R33 · FY2023 · AA
MOUD Comparative Effectiveness Study$530,704
R01 · FY2022 · DA · contact PI
Records for Alcohol Care Enhancement (RACE)$388,788
R33 · FY2022 · AA
MOUD Comparative Effectiveness Study$602,367
R01 · FY2021 · DA · contact PI
Records for Alcohol Care Enhancement (RACE)$411,746
R33 · FY2021 · AA
Improving urine drug test utility to mitigate prescription opioid risk$191,114
K23 · FY2021 · DA · contact PI
Improving urine drug test utility to mitigate prescription opioid risk$191,114
K23 · FY2020 · DA · contact PI
Improving urine drug test utility to mitigate prescription opioid risk$191,114
K23 · FY2019 · DA · contact PI
Heroin use and overdose following changes to individual-level opioid prescribing$400,000
U01 · FY2018 · CE
Improving urine drug test utility to mitigate prescription opioid risk$191,114
K23 · FY2018 · DA · contact PI
Heroin use and overdose following changes to individual-level opioid prescribing$399,823
U01 · FY2017 · CE
Improving urine drug test utility to mitigate prescription opioid risk$191,114
K23 · FY2017 · DA · contact PI